What is ARVN's dilution risk score?

ARVN has a latest available DilutionScore record of 31/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ARVN, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ARVN?

DilutionWatch tracks 25 SEC filing types for ARVN including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ARVN shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ARVN, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ARVN tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ARVN. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ARVN Dilution Risk Score: 31/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

25

📊 Float Risk

5

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for ARVN.

🔔 Track ARVN — Get forecast alerts →

Market Data

Market Cap$579.40M

Shares Outstanding65.39M

Float55.95M

Cash$567.90M

Debt$500.0K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 10.5% shares (2026Q1 vs prior)

208 institutional holders · 62.85M shares

#1 BlackRock, Inc. 6.80M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 5.38M shares

#3 VANGUARD PORTFOLIO MANAGEMENT LLC 3.89M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.00M

Days to Cover7.0

% of Float7.1%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2023-12-31

xbrl XBRL CONVERTIBLE 2018-12-31

4 INSIDER TRANSACTION 2026-03-19

4 INSIDER TRANSACTION 2026-03-09

4 INSIDER TRANSACTION 2026-03-02

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual ARVN Dilution Snapshot

Arvinas, Inc. (ARVN) has a DilutionScore of 31/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for ARVN: 4 on 2026-03-19; 4 on 2026-03-09; 4 on 2026-03-02.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

More Research for ARVN

ARVN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

ARVN — Arvinas, Inc. Dilution Risk Tracker